
"JP Morgan's Confidence in New CEO Boosts Walgreens Stock"
Walgreens stock received a boost after J.P. Morgan expressed confidence in new CEO Tim Wentworth's ability to reduce overhangs and improve the pharmacy chain's performance. The analysts believe that Wentworth's expertise in healthcare services will benefit the company and its relationships across the healthcare industry. J.P. Morgan upgraded its stock price target from $27 to $30.
